Topics

More News! Lynparza strikes again, the avocado genome sequenced, the TARDIS, and more…

12:12 EDT 9 Aug 2019 | Labiotech.eu

Try as we might, we can’t cover all the fascinating biotech news that is out there. So chill out, relax and check out what hasn’t quite made the cut over the last week.  Clinical trials Lynparza, AstraZeneca’s approved drug for treating ovarian and breast cancer, has sailed through a phase III trial for treating prostate […]

The post More News! Lynparza strikes again, the avocado genome sequenced, the TARDIS, and more… appeared first on Labiotech.eu.

Original Article: More News! Lynparza strikes again, the avocado genome sequenced, the TARDIS, and more…

NEXT ARTICLE

More From BioPortfolio on "More News! Lynparza strikes again, the avocado genome sequenced, the TARDIS, and more…"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...